Hemab Therapeutics Holdings, Inc.
Hemab Therapeutics Holdings, Inc. is tracked here for clinical trial milestones, SEC filings and earnings dates. Focus area: Biological Products, (No Diagnostic Substances).
The next scheduled catalyst is A First-in-Human Study to Assess the Safety, Pharmacokinetics, and Pharmacodynamics of HMB-003 in Healthy Volunteers on April 30, 2027. There are 4 upcoming events on record.
Cash runway is approximately 63.6 months based on the most recent reported cash position and quarterly operating burn as of 2026-06-30.
| Date | Event | Type | Phase |
|---|---|---|---|
| April 30, 2027 | A First-in-Human Study to Assess the Safety, Pharmacokinetics, and Pharmacodynamics of HMB-003 in Healthy Volunteers | Trial Milestone | Phase 1 |
| July 15, 2027 | A Study Assessing HMB-002 in Participants With Von Willebrand Disease | Trial Milestone | Phase 1/Phase 2 |
| August 15, 2027 | A Phase 1/2 Study to Investigate Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Efficacy of HMB-001 in Glanzmann Thrombasthenia | Trial Milestone | Phase 1/Phase 2 |
| November 15, 2027 | A Clinical Study to Assess Sutacimig in Participants With Congenital Factor VII Deficiency | Trial Milestone | Phase 2 |
Track COAG alongside other companies. Add it to a watchlist and see every catalyst on one calendar.
Open COAG in the tracker| Date | Event | Type | Phase |
|---|---|---|---|
| September 24, 2026 | 8-K filed: Leadership change | Corporate | — |
| August 11, 2026 | Quarterly results filed (8-K) | Earnings | — |
| May 21, 2026 | Quarterly results filed (8-K) | Earnings | — |
| May 11, 2026 | 8-K filed: Leadership change | Corporate | — |
| May 4, 2026 | 8-K filed: Other event | Filing | — |
Trial milestones come from the ClinicalTrials.gov v2 API, filings from SEC EDGAR, and financial figures from SEC XBRL company facts. Dates marked est. are projected rather than company-confirmed. This is an information tool, not investment advice — verify anything you act on against the linked primary source.
Last updated 2026-10-14.